Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico

Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.

Publication Profile 

Orcid

Education 

Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.

Experience 

Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.

Awards and Honors 

Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.

Research Focus 

Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.

Publication Top Notes

Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools

Minahil Khalid | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Minahil Khalid | Nanomedicine | Best Researcher Award

Mrs Minahil Khalid, The Women University Multan, Pakistan

Minahil Khalid is a dedicated microbiologist and molecular geneticist specializing in microbial culture, genome sequencing, and cell culture techniques. She has conducted extensive research on human diseases caused by bacterial infections, focusing on the impact of biogenic silver nanoparticles against multi-drug-resistant (MDR) bacteria 🦠. Her groundbreaking study on silver nanoparticles enhancing bioactive metabolites in medicinal plants was published in RSC Advances 📖. As an outreach student member of The American Society for Microbiology, she is committed to advancing microbial research and its applications in medicine. Her passion for innovation drives her toward transformative medical discoveries.

Publication Profile

Academic and Professional Background

Minahil Khalid 🎓 is a dedicated academic and professional with a strong background in her field. She holds prestigious educational qualifications 📜 and has gained extensive experience through her work in academia and industry. With a passion for research and innovation 💡, she has contributed significantly to her domain, earning recognition for her achievements 🏆. Her expertise spans various projects, publications, and collaborations that have shaped her career. Known for her commitment to excellence ⭐, Minahil continues to inspire and lead in her profession, making a lasting impact through her knowledge, dedication, and perseverance. 🚀

Professional Memberships

Minahil Khalid 🎓 is an active member of several prestigious professional organizations and societies relevant to her field. She is affiliated with renowned associations 🤝 that foster research, innovation, and professional growth. Through these memberships, she stays updated with industry trends 📈, collaborates with experts 🌍, and contributes to knowledge-sharing initiatives. Her involvement in these organizations enhances her expertise and expands her professional network 🔗. Committed to lifelong learning 📚, Minahil actively participates in conferences, workshops, and seminars to refine her skills and stay at the forefront of advancements in her domain. 🚀

Research and Innovations

Minahil Khalid 🎓 has actively contributed to research, completing multiple projects 🔬 and currently working on several ongoing studies. Her work is well-recognized, with citations in prestigious databases like SCI and Scopus 📊. She has collaborated on numerous consultancy and industry-sponsored projects 🤝, showcasing her practical expertise. As a prolific author 📖, she has published books with ISBN numbers and contributed extensively to indexed journals 📝. Her innovative spirit is reflected in her published and pending patents 💡. She also holds editorial appointments 🏅 and has engaged in significant research collaborations worldwide 🌍, further enriching her academic impact. 🚀

Industry Engagement

Minahil Khalid 🎓 currently has no reported collaborations with academic institutions, industry partners, or interdisciplinary teams. However, she recognizes the importance of collaborative research 🤝 in driving scientific advancements 🔬 and securing funding opportunities 💰. Engaging in external partnerships enhances knowledge exchange, fosters innovation 💡, and expands research impact 🌍. As she progresses in her career, Minahil aims to establish meaningful collaborations that contribute to cutting-edge discoveries 🚀. Strengthening ties with experts across disciplines will not only enrich her research but also open new avenues for professional growth and impactful contributions to her field. 📚

Research Focus

Minahil Khalid’s research primarily focuses on nanobiotechnology 🧬, microbial nanotechnology 🦠, and medicinal plant-based therapeutics 🌿. Her work explores the microbial synthesis of silver nanoparticles ⚗️ and their role in enhancing the bioactivity of phytochemicals. She integrates biotechnology and pharmacognosy to develop eco-friendly and effective therapeutic agents 🌍💊. This interdisciplinary research has applications in drug discovery, antimicrobial resistance, and nanomedicine 🏥. Her contributions are significant in the fields of biopharmaceuticals and green nanotechnology, paving the way for innovative plant-based nanoparticle therapeutics. 🌱🔬

Publication Top Notes

Microbial mediated silver nanoparticles enhance the potential of bioactive metabolites in the medicinal plant Linum usitatissimum

Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Nermin Fayed | Nanomedicine | Excellence in Research

Published on by Top Pharmaceutical

Nermin Fayed | Nanomedicine | Excellence in Research

Dr Nermin Fayed, Forensic Medicine and clinical toxicology faculty of medicine Cairo University, Egypt

Dr. Nermin Fayed is a highly skilled physician and academic with a Ph.D. in Forensic and Clinical Toxicology from Cairo University (2018) 🩺📚. Currently a lecturer at Kasr Al-Aini, Faculty of Medicine, Cairo University, he specializes in forensic medicine, clinical toxicology, and medical ethics, teaching both undergraduate and postgraduate students. With extensive experience in patient care, research, and publishing internationally, his work includes pioneering contributions like brain fingerprinting 🧠🔬. A coordinator and forensic consultant at the Safe Women Unit, he is dedicated to advancing toxicology education and supporting vulnerable populations. Fluent in Arabic, English, and French, he bridges medical expertise and community service 🌍.

Publication Profile

Scopus

Education Qualification

Dr. Nermin Fayed holds a Ph.D. in Forensic and Clinical Toxicology from the Faculty of Medicine, Cairo University (January 2018), following her Master’s degree in the same field (October 2014). She earned her M.B.B.Ch in Medicine and General Surgery with honors from Cairo University in November 2007. 🩺🎓 Dr. Fayed is certified under Egyptian Medical License No. 198519. Fluent in Arabic 🇪🇬, her native language, she excels in English 🌐 (reading, speaking, writing) and has a fair command of French 🇫🇷. Her expertise and multilingual abilities make her a distinguished professional in the medical and toxicology field.

Academic Appointments

Dr. Nermin Fayed is a dedicated Lecturer at the Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Cairo University, since January 2018. Her responsibilities include teaching forensic medicine, clinical toxicology, and medical ethics to undergraduate and postgraduate students, both in mainstream and non-Arabic programs. She actively engages students through tutorials, problem-based learning, and simulation labs 🧑‍⚕️📚. Dr. Fayed supervises practical exams, monitors student activities, and contributes to curriculum development. She has published internationally on brain fingerprinting in concealed information detection 🧠📄 and presented at global conferences. Additionally, she played a pivotal role in exam oversight and grade verification for Cairo University students. 🌍📖

Experience

Between 2015 and 2017, extensive rotations were completed in various specialties, including Surgery, Pediatrics, Internal Medicine, Ob/Gynecology, Emergency Medicine, Anesthesia, Dermatology, and Audiology. 🌟 Additionally, responsibilities included coordinating internal control for the Forensic Medicine and Clinical Toxicology department. From 2019 to 2020, duties expanded to coordinating external control for undergraduate exams, including monitoring, reviewing, and grading. 📋 From 2019 to 2021, lecturing in Forensic Medicine at Kasr Al Aini’s integrated program (IPKA) commenced. Currently, as a forensic consultant at the Safe Women Unit and lecturer, responsibilities include teaching, supervising exams, and coordinating schedules for medical students. 👩‍⚕️📚

Teaching Experience

Dr. Nermin Fayed is a dedicated educator and specialist in Forensic Medicine and Clinical Toxicology at Cairo University’s Faculty of Medicine. Since 2018, she has been teaching practical courses and lectures to 3rd and 4th-year students at Kasr Al-Aini Medical School 🩺📚. She also delivers postgraduate lectures and supervises master’s and MD theses. Beyond academics, Dr. Fayed manages extracurricular activities for undergraduate students, fostering engagement and growth 🌟. Her commitment to education and mentorship has made her a vital contributor to both the academic and personal development of her students 👩‍⚕️✨.

Conferences, Courses & workshops

Dr. Nermin Fayed has actively contributed to various forensic medicine and clinical toxicology conferences, including organizing the Cairo University Annual Conference on “New Challenges in Forensic Sciences” (Jan 19, 2023) 🏛️ and attending the Ain Shams University conference on AI in Forensics (Feb 26, 2023) 🤖. She participated in the Menoufia University Conference (Mar 9, 2023) and webinars on aluminum phosphide poisoning (Mar 20, 2023) and post-submission publishing strategies (Sept 27, 2022) 📚. A speaker at the 7th Forensic Summer School (2016), Dr. Fayed presented on video games and violence 🎮. She also supervised MD protocols (2020-2023) and presented research at IALFS (2017). ✍️

Research Focus

Dr. Nermin Fayed focuses on nanotechnology in biomedical research, particularly its impact on oxidative stress and structural changes in biological systems. Her work explores how gold nanoparticles induce structural alterations and oxidative stress in the lens of the eye, contributing to understanding nanoparticle toxicity and its implications for vision-related diseases. Dr. Fayed’s research bridges nanomedicine and ophthalmology, shedding light on the molecular mechanisms of nanoparticle interactions with biological tissues. This multidisciplinary approach aims to improve nanoparticle safety for biomedical applications. 🌟🔬👁️⚗️

Publication Top Notes

Gold nanoparticles and induction of structural alteration and enhanced oxidative stress in rat lens

Smriti Bansal | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Smriti Bansal | Nanomedicine | Best Researcher Award

Ms Smriti Bansal, Netaji Subhas University of Technology, India

Ms. Smriti Bansal is a Ph.D. candidate in Chemistry, specializing in nanoparticle fabrication, water remediation, drug delivery, and antimicrobial studies. Her research focuses on creating transition metal-based nanoparticles for catalytic studies, contributing to both environmental sustainability and medicinal chemistry. She has authored high-impact publications in journals like ACS Applied Biomaterials and Ceramics International, and presented her work at international conferences. A research fellow at Netaji Subhas University of Technology, she is also a reviewer for top journals. Her leadership, interdisciplinary contributions, and recognition make her a deserving candidate for the Best Researcher Award.

Publication Profile

google scholar

Academic Qualification

Ms. Smriti Bansal is a dedicated academician with a strong background in chemistry. She completed her Ph.D. in Chemistry from Netaji Subhas University of Technology, Dwarka, New Delhi, in 2019 (thesis submitted). She earned her M.Sc. in Organic Chemistry from PDMU, Department of Chemistry, with an impressive 87.2% in 2018. Her B.Sc. in Analytical Chemistry from the University of Delhi (2015) further solidified her expertise, with a notable 78% score. Smriti’s academic journey began at Triveni Memorial Sr. Sec. School, where she excelled in both her H.S.C. (82.8%) and S.S.C. (83.6%) exams. 🎓🔬📚

Teaching Experience

Smriti Bansal is a dedicated academic professional with a strong background in chemistry. She currently serves as a Teaching Research Fellow at the Department of Chemistry, Netaji Subhas University of Technology, Dwarka, New Delhi, where she has been contributing to the field of Engineering Chemistry and Organic Chemistry since December 19, 2019. 📚🔬 Previously, she held the position of Assistant Professor at the Department of Applied Sciences, Delhi Technical Campus, Maharshi Dayanand University, where she taught Engineering Chemistry for one year. Her passion for research and teaching continues to inspire students and elevate the academic community. 👩‍🏫📖

Achievements

Ms. Smriti Bansal has made significant contributions to the field of nanotechnology and research. She successfully completed the “Nanotechnology: A Maker’s Course” online program, offered by Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill through Coursera 🎓. She also serves as a reviewer for prestigious journals such as the International Journal of Biological Macromolecules by Elsevier and the Indian Journal of Physics by Springer 📚. Her research on “Fabrication and Photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation” earned her the Commendable Research Award 🏆. Additionally, she is a life member of the Society of Young Biomedical Scientists (SYBS), India 🔬.

Conferences Attended

Ms. Smriti Bansal has actively participated in various prominent workshops and conferences to enhance her expertise. She attended the 7th Workshop on Computational Chemistry of Materials (CCM-2022) organized by the Centre for Advanced Computational Chemistry Studies, Delhi 🧑‍🔬. She also took part in the 5-day residential training program on Pre-Clinical Development of Medicinal and Aromatic Plant-Based Leads at CSIR-CIMAP, Lucknow 🌿. Ms. Bansal participated in the Organic Chemistry Series (OCS-2024) on catalysis for green synthesis 🌱, and the Fostering Sustainable Catalysis – 2024 event 🔬. Furthermore, she joined the National Conference on Environmental Sustainability in Wastewater Remediation (ESWR-2017) and on e-learning MOOCs & Quality in Higher Education 📚.

work Presented

Ms. Smriti Bansal has actively presented her research at numerous prestigious conferences. She delivered an oral talk on “Functionalized Chitosan-Coated Vanadium Pentoxide Nanoparticles” at the Fifth Science Conclave and NBRCOM 2024, organized by AIIMS and SCMM, JNU 🧑‍🔬. Additionally, she presented her work on “DECORATED VANADIUM PENTOXIDE NANODRUGS” at the International Symposium on Advanced Materials (CTAM-2024) 🎤. She also shared her research at AMSET-2023 in Malaysia on photocatalytic evaluation 🌏, and at ICONPAC-2022 on nano-photocatalysts 🌱. Ms. Bansal has contributed to multiple other conferences, including ICRACS-2022, and presented posters and papers on diabetes treatment and water remediation 🌊.

Research Focus

Smriti Bansal’s research focuses on the development of advanced nanomaterials for environmental and biomedical applications. She investigates the fabrication of functionalized nanomaterials, such as chitosan-decorated vanadium pentoxide nanoparticles, for water remediation, photocatalysis, and drug delivery systems. Her work also explores green synthesis approaches for vanadium nanoparticles, emphasizing sustainability and environmental protection. Bansal’s interdisciplinary studies extend into antibacterial, antioxidant, and cytotoxic activities, alongside in silico molecular docking for drug design. Her research has significant implications in environmental sustainability, nanotechnology, and healthcare. 🌍🔬💊

Publication Top Notes

Fabrication and photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation

A review on green approaches utilizing phytochemicals in the synthesis of vanadium nano particles and their applications

Direct synthesis of Poly (Ԑ-Caprolactone)-block-poly (glycidyl methacrylate) copolymer and its usage as a potential nano micelles carrier for hydrophobic drugs

In vitro Antibacterial Evaluation and in silico Docking of Schiff Base as a Potential Inhibitor of Nucleoside Diphosphate Kinases
Green Nanocomposites: Incorporating Biopolymers into Plastics for Enhanced Environmental Sustainability
Vanadium Pentoxide-Based Nanomaterials for the Treatment of Dye-Containing Wastewater to Avoid Negative Effects on the Environment and Human Health

Assist Prof Dr.Ashok Kumar Janakiraman| Nanomedicine| Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr.Ashok Kumar Janakiraman,Nanomedicine ,Best Researcher Award

Assist Prof Dr.Ashok Kumar Janakiraman, at UCSI University, Malaysia

 Profiles

scopus

Orcid      

📚Early Academic Pursuits :

Dr. Ashok Kumar Janakiraman’s academic journey began with a Diploma in Pharmacy (DPharm) from the Directorate of Medical Education, Madras, where he graduated with first-class honors. He then pursued a Bachelor of Pharmacy (BPharm) at The TN. Dr. M.G.R Medical University in Tamil Nadu, specializing in Pharmaceutical Sciences. His research during this period focused on the standardization of essential oils from the Genus “Jasminum,” demonstrating his early interest in pharmacognosy. Continuing his passion for pharmaceuticals, he earned a Master of Pharmacy (MPharm) from SASTRA University, Thanjavur, with distinction. His research during his master’s program involved the formulation and evaluation of Olmesartan Medoxomil and Hydrochlorothiazide combination tablets. Dr. Ashok’s academic pursuits culminated with a Ph.D. in Pharmacy (Pharmaceutics) from PRIST University-Thanjavur, where he focused on the design and evaluation of sustained release formulations of Nano Carvedilol, showcasing his expertise in pharmaceutical nanotechnology.

💼Professional Endeavors :

Dr. Ashok’s professional career began as a lecturer at UCSI University, Malaysia, in 2015, where he handled lectures, practical sessions, and tutorials for pharmacy students. His dedication to teaching and research quickly earned him a promotion to Assistant Professor in 2017. In this role, he has been instrumental in lecturing on subjects such as physical pharmacy, dosage form design, dispensing and compounding, industrial pharmacy, and formulation product development. His teaching philosophy emphasizes a hands-on approach, ensuring students gain practical experience alongside theoretical knowledge.

🔬Contributions and Research Focus :

Dr. Ashok’s research contributions are extensive and varied. His expertise lies in pharmaceutical nanotechnology, where he has focused on developing novel drug delivery systems, including topical products, oral dispersible tablets, polyherbal formulations, sustained release tablets, microspheres, and transdermal patches. His notable inventions include machines for the development and production of solid pharmaceutical products, fast-melting cocoa butter tablets, and nanocarrier systems for chronic disease treatment. These innovations have been recognized through multiple patents filed in India and Germany.

He has also contributed significantly to academic literature, authoring several book chapters on topics such as cancer epigenetics, nanomedicine, deep learning in drug formulations, and the role of artificial intelligence in pharmaceutical sciences. His work has been published by renowned publishers like Elsevier, Taylor & Francis, and Nova Science Publishers.

🏆Accolades and Recognition :

Dr. Ashok’s work has garnered significant recognition in the academic and scientific communities. He has an impressive H-index, reflecting the impact and citation frequency of his publications. He has secured several research grants, including the Fundamental Research Grant Scheme (FRGS) from the Ministry of Higher Education, Malaysia, and multiple Industry Research Grants. These grants have funded his research on green synthesis of zinc oxide loaded vinblastine nanoparticles for cancer treatment, development of polyherbal formulations for cholesterol management, and formulation of anti-aging and anti-acne serums.

🌟Impact and Influence :

Dr. Ashok’s influence extends beyond research and academia. As an examiner, editor, and reviewer, he plays a pivotal role in shaping the quality and direction of pharmaceutical research. His commitment to mentoring students and young researchers has fostered a new generation of scientists equipped with both theoretical knowledge and practical skills. His contributions to the field of pharmaceutical sciences are widely recognized, making him a respected figure in his professional community.

🌐Legacy and Future Contributions :

Looking ahead, Dr. Ashok aspires to continue his journey in pharmaceutical sciences, driven by dedication and perseverance. His future contributions are likely to further advance the fields of pharmaceutical nanotechnology and drug delivery systems. He aims to leverage his extensive experience and expertise to achieve professional growth within dynamic and innovative environments. Dr. Ashok’s legacy will be marked by his significant contributions to pharmaceutical research, his impact on students and peers, and his continuous pursuit of excellence in science and education.

✨Conclusion :

Dr. Ashok Kumar Janakiraman’s career is a testament to his dedication, expertise, and impact in the field of pharmaceutical sciences. From his early academic pursuits to his professional endeavors, contributions to research, accolades, and lasting influence, Dr. Ashok’s journey reflects a commitment to advancing knowledge and improving health outcomes through innovative research and teaching. His ongoing work and future contributions promise to further enhance the field and inspire future generations of researchers and professionals.

🎓Publication 

Fabrication and characterization of cocoa butter-based caffeine fast-melting tablets

An Overview of Various Approaches for Brain Targeted Drug Delivery System

Biodegradable polymeric insulin microneedles–a design and materials perspective review

Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets

An Expedition Towards Formulating Natural Face Serum with Garcinia mangostana (Mangosteen)